This study is just more evidence of the dangers associated with the use of transvaginal mesh in pelvic organ prolapse repair.
New York, NY (PRWEB) March 19, 2013
As transvaginal mesh lawsuits continue to move through the courts, a new study presented at the Annual Congress of the European Association of Urology is pointing to risk factors that may predict which women are most vulnerable to mesh implant complications, according to Bernstein Liebhard LLP. The study, which followed 677 women who had undergone pelvic organ prolapse repair with trocar-guided transvaginal mesh, found that younger age, less prominent prolapse and concomitant hysterectomies were associated with a higher risk of transvaginal mesh complications. Injuries seen among the study participants included mesh erosion, mesh shrinkage, pain during sexual intercourse, pelvic abscesses, and pelvic, vaginal and perineal hematomas.*
“This study is just more evidence of the dangers associated with the use of transvaginal mesh in pelvic organ prolapse repair. The injuries seen in this study echo those suffered by our own clients, many of whom also had some of the same risk factors prior to their prolapse surgery,” says Bernstein Liebhard LLP, a nationwide law firm representing the victims of defective drugs and medical devices, including numerous women in transvaginal mesh lawsuits. The Firm continues to offer free legal evaluations to victims of transvaginal mesh complications associated with products manufactured by American Medical Systems, Inc., Boston Scientific Corp., C.R. Bard, Inc. and Johnson & Johnson’s Ethicon, Inc. subsidiary.
Transvaginal Mesh Complications
Transvaginal mesh complications have been a subject of concern since October 2008, when the U.S. Food & Drug Administration (FDA) revealed that it had received more than 1,000 reports of serious mesh implant complications over a three year period.** In July 2011, the FDA issued an update to that alert, warning that there had been a five-fold increase in reports of serious complications associated with the use of transvaginal mesh. The FDA also modified its previous position on the frequency of such complications, stating in the alert that vaginal mesh injuries associated with pelvic organ prolapse repair were not rare.***
Since the FDA issued those alerts, thousands of women have filed transvaginal mesh lawsuits after allegedly suffering serious mesh implant complications following surgery to repair pelvic organ prolapse and stress urinary incontinence. Many of those claims have been consolidated in four multidistrict litigations that are currently underway in U.S. District Court, Southern District of West Virginia: In re: American Medical Systems, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2325”); In re: Boston Scientific Corp., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2326); In re: C.R. Bard, Inc., Pelvic Repair Systems Products Liability Litigation (“MDL No. 2187”); and In re: Ethicon, Inc., Pelvic Repair Systems Products Liability Litigation (“ MDL No. 2327”). Bernstein Liebhard LLP partner, Jeffrey S. Grand, is serving on the Plaintiffs’ Steering Committees in all of these proceedings.
Two consolidated proceedings involving vaginal mesh claims are also underway in New Jersey Superior Court, Atlantic County, involving products manufactured by Ethicon Inc. and C.R. Bard. (In re: Pelvic Mesh Litigation/Bard, No. L-6339-10, and In re: Pelvic Mesh/Gynecare Litigation, No. 6341-10). Bernstein Liebhard LLP partner, Jeffrey Grand is serving as Co-Liaison Counsel in both of these litigations. Earlier this month, the nation’s first trial involving an Ethicon mesh product concluded in the New Jersey litigation, with the jury awarding more than $11 million to the Plaintiff, including $7.76 million in punitive damages. (Gross v. Gynecare Inc., Atl-L-6966-10, Superior Court of Atlantic County, New Jersey (Atlantic City))
Victims of mesh implant complications may be entitled to compensation for their medical bills, pain and suffering, and other injuries. A wealth of information regarding transvaginal mesh lawsuits can be found at Bernstein Liebhard's website. To learn more, please call 1-877-779-1414.
About Bernstein Liebhard LLP
Bernstein Liebhard LLP is a New York-based law firm exclusively representing injured persons in complex individual and class action lawsuits nationwide since 1993, including those who have been harmed by dangerous drugs, defective medical devices and consumer products. The firm has been named by The National Law Journal to the “Plaintiffs’ Hot List,” recognizing the top plaintiffs’ firms in the country, for the past 10 consecutive years.
Bernstein Liebhard LLP
10 East 40th Street
New York, New York 10016
ATTORNEY ADVERTISING. © 2013 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter.
# # #
Felecia L. Stern, Esq.
Bernstein Liebhard LLP